Literature DB >> 19341304

Enzyme activity of phosphatase of regenerating liver is controlled by the redox environment and its C-terminal residues.

Andria L Skinner1, Anthony A Vartia, Todd D Williams, Jennifer S Laurence.   

Abstract

Phosphatase of regenerating liver-1 (PRL-1) belongs to a unique subfamily of protein tyrosine phosphatases (PTPases) associated with oncogenic and metastatic phenotypes. While considerable evidence supports a role for PRL-1 in promoting proliferation, the biological regulators and effectors of PRL-1 activity remain unknown. PRL-1 activity is inhibited by disulfide bond formation at the active site in vitro, suggesting PRL-1 may be susceptible to redox regulation in vivo. Because PRL-1 has been observed to localize to several different subcellular locations and cellular redox conditions vary with tissue type, age, stage of cell cycle, and subcellular location, we determined the reduction potential of the active site disulfide bond that controls phosphatase activity to improve our understanding of the function of PRL-1 in various cellular environments. We used high-resolution solution NMR spectroscopy to measure the potential and found it to be -364.3 +/- 1.5 mV. Because normal cellular environments range from -170 to -320 mV, we concluded that nascent PRL-1 would be primarily oxidized inside cells. Our studies show that a significant conformational change accompanies activation, suggesting a post-translational modification may alter the reduction potential, conferring activity. We further demonstrate that alteration of the C-terminus renders the protein reduced and active in vitro, implying the C-terminus is an important regulator of PRL-1 function. These data provide a basis for understanding how subcellular localization regulates the activity of PRL-1 and, with further investigation, may help reveal how PRL-1 promotes unique outcomes in different cellular systems, including proliferation in both normal and diseased states.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19341304      PMCID: PMC2759777          DOI: 10.1021/bi900241k

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  69 in total

1.  Developmental expression of the murine Prl-1 protein tyrosine phosphatase gene.

Authors:  C H Rundle; C Kappen
Journal:  J Exp Zool       Date:  1999-05-01

2.  DITHIOTHREITOL, A NEW PROTECTIVE REAGENT FOR SH GROUPS.

Authors:  W W CLELAND
Journal:  Biochemistry       Date:  1964-04       Impact factor: 3.162

Review 3.  Protein tyrosine phosphorylation and reversible oxidation: two cross-talking posttranslation modifications.

Authors:  Paola Chiarugi; Francesca Buricchi
Journal:  Antioxid Redox Signal       Date:  2007-01       Impact factor: 8.401

4.  Prenylation of oncogenic human PTP(CAAX) protein tyrosine phosphatases.

Authors:  C A Cates; R L Michael; K R Stayrook; K A Harvey; Y D Burke; S K Randall; P L Crowell; D N Crowell
Journal:  Cancer Lett       Date:  1996-12-20       Impact factor: 8.679

5.  PRL3 promotes cell invasion and proliferation by down-regulation of Csk leading to Src activation.

Authors:  Fubo Liang; Jiao Liang; Wei-Qing Wang; Jin-Peng Sun; Eshwar Udho; Zhong-Yin Zhang
Journal:  J Biol Chem       Date:  2006-12-27       Impact factor: 5.157

6.  Redox potentials of glutaredoxins and other thiol-disulfide oxidoreductases of the thioredoxin superfamily determined by direct protein-protein redox equilibria.

Authors:  F Aslund; K D Berndt; A Holmgren
Journal:  J Biol Chem       Date:  1997-12-05       Impact factor: 5.157

7.  PRL-1 tyrosine phosphatase regulates c-Src levels, adherence, and invasion in human lung cancer cells.

Authors:  Hiroyuki Achiwa; John S Lazo
Journal:  Cancer Res       Date:  2007-01-15       Impact factor: 12.701

8.  High PRL-3 expression in human gastric cancer is a marker of metastasis and grades of malignancies: an in situ hybridization study.

Authors:  U A Miskad; S Semba; H Kato; Y Matsukawa; Y Kodama; E Mizuuchi; N Maeda; K Yanagihara; H Yokozaki
Journal:  Virchows Arch       Date:  2007-01-18       Impact factor: 4.064

9.  PRL-1, a protein tyrosine phosphatase, is expressed in neurons and oligodendrocytes in the brain and induced in the cerebral cortex following transient forebrain ischemia.

Authors:  S Takano; H Fukuyama; M Fukumoto; J Kimura; J H Xue; H Ohashi; J Fujita
Journal:  Brain Res Mol Brain Res       Date:  1996-08

10.  Redox-regulated conformational changes in an SH3 domain.

Authors:  Jürgen Zimmermann; Ronald Kühne; Marc Sylvester; Christian Freund
Journal:  Biochemistry       Date:  2007-05-19       Impact factor: 3.162

View more
  11 in total

1.  Characterization of the Protein Tyrosine Phosphatase LmPRL-1 Secreted by Leishmania major via the Exosome Pathway.

Authors:  Sabine Leitherer; Joachim Clos; Elisabeth M Liebler-Tenorio; Ulrike Schleicher; Christian Bogdan; Didier Soulat
Journal:  Infect Immun       Date:  2017-07-19       Impact factor: 3.441

2.  Probing residue-specific interactions in the stabilization of proteins using high-resolution NMR: a study of disulfide bond compensation.

Authors:  Andria L Skinner; Jennifer S Laurence
Journal:  J Pharm Sci       Date:  2010-06       Impact factor: 3.534

3.  PRL3 pseudophosphatase activity is necessary and sufficient to promote metastatic growth.

Authors:  Guennadi Kozlov; Yosuke Funato; Yu Seby Chen; Zhidian Zhang; Katalin Illes; Hiroaki Miki; Kalle Gehring
Journal:  J Biol Chem       Date:  2020-06-22       Impact factor: 5.157

4.  Reversion of sulfenamide prodrugs in the presence of free thiol-containing proteins.

Authors:  Kwame W Nti-Addae; Jennifer S Laurence; Andria L Skinner; Valentino J Stella
Journal:  J Pharm Sci       Date:  2011-02-03       Impact factor: 3.534

Review 5.  Phosphatase of regenerating liver: a novel target for cancer therapy.

Authors:  Amanda M Campbell; Zhong-Yin Zhang
Journal:  Expert Opin Ther Targets       Date:  2014-03-01       Impact factor: 6.902

6.  Integrated analysis of global mRNA and protein expression data in HEK293 cells overexpressing PRL-1.

Authors:  Carmen M Dumaual; Boyd A Steere; Chad D Walls; Mu Wang; Zhong-Yin Zhang; Stephen K Randall
Journal:  PLoS One       Date:  2013-09-03       Impact factor: 3.240

7.  Genome-wide functional genetic screen with the anticancer agent AMPI-109 identifies PRL-3 as an oncogenic driver in triple-negative breast cancers.

Authors:  Hamid H Gari; Christy M Gearheart; Susan Fosmire; Gregory D DeGala; Zeying Fan; Kathleen C Torkko; Susan M Edgerton; M Scott Lucia; Rahul Ray; Ann D Thor; Christopher C Porter; James R Lambert
Journal:  Oncotarget       Date:  2016-03-29

8.  Mutational Analysis of a Conserved Glutamate Reveals Unique Mechanistic and Structural Features of the Phosphatase PRL-3.

Authors:  Birgit Hoeger; Pablo Rios; Anna Berteotti; Bernhard Hoermann; Guangyou Duan; Maja Köhn
Journal:  ACS Omega       Date:  2017-12-22

9.  Drosophila PRL-1 is a growth inhibitor that counteracts the function of the Src oncogene.

Authors:  Krystle T Pagarigan; Bryce W Bunn; Jake Goodchild; Travis K Rahe; Julie F Weis; Leslie J Saucedo
Journal:  PLoS One       Date:  2013-04-08       Impact factor: 3.240

10.  PRL2 Controls Phagocyte Bactericidal Activity by Sensing and Regulating ROS.

Authors:  Cennan Yin; Chenyun Wu; Xinyue Du; Yan Fang; Juebiao Pu; Jianhua Wu; Lili Tang; Wei Zhao; Yongqiang Weng; Xiaokui Guo; Guangjie Chen; Zhaojun Wang
Journal:  Front Immunol       Date:  2018-11-13       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.